... and uncomparative nature.RN with CT using ECC and DHCA is a challenging procedure which requires a dedicated multidisciplinary working team to minimise complications and maximise patients' outcomes.Patients with kidneycancer and a thrombus within the inferior vena cava, which reaches above the diaphragm, can be treated with surgery.
Abstract: Renal cell carcinomas with MITF aberrations demonstrate a wide morphologic spectrum, highlighting the need to consider these entities within the differential diagnosis of renaltumors encountered in clinical practice... Ninety-eight percent of renaltumors submitted for FISH evaluation were from adult patients. Thirty-one (37%) tumors were confirmed to demonstrate MITF aberrations (21 TFE3 translocation, 4 TFEB translocation ...
... ORs).Sixteen studies (n = 3958 patients) comparing EBRT versus no EBRT, including one randomized controlled trial (RCT) in extremity sarcoma, were analyzed. EBRT appeared to reduce LR in both retroperitonealtumors (OR 0.47, p < 0.0001) and other locations (OR 0.49, p = 0.001. OS was improved by EBRT in retroperitoneal STSs (OR 0.37, p < 0.0001) but not in other tumor locations.
... nephrectomy should minimise the ischaemic effect on the renal parenchyma whenever possible. This has to be carried out with precision and based on the vascular anatomy of the kidney AbstractText: In this report, we tried to describe the best practice for the suturing of renal parenchyma after conservative surgical treatment for small renaltumours... Keyword: Kidneyneoplasms. Keyword: Partial nephrectomy.
AbstractText: Renalcancer surgery (RCS) can adversely impact long-term function and survival. We evaluate predictors of chronic kidney disease (CKD) at 5-years and non-renalcancer mortality (NRCM) 10-years after RCS AbstractText: We analyzed 4,283 patients undergoing ... Keyword: non-renalcancer-related survival... Keyword: renalcancer surgery.
AbstractText: Factors associated with malignancy in patients with pheochromocytoma (adrenaltumors, Pheo) and paraganglioma (extra-adrenal, PGL) are not well-defined and all patients require lifelong surveillance. The primary aim of our study was to determine genetic and clinical variables associated with malignancy in patients with Pheo/PGL AbstractText: Single institution retrospective review was performed of all patients who underwent ...
Oncology (1) Neoplasms (6), Pheochromocytoma (2), Paraganglioma (2), more mentions
... prognostic role of VAV2 expression in ACC by investigation of a large cohort of patients.A total of 171 ACC cases (157 primary tumors, six local recurrences, eight metastases) from seven European Network for the Study of AdrenalTumors centers were studied.H-scores were generated to quantify VAV2 expression.
The International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI) have initiated a series of cancer-focused seminars [Scelo G, Hofmann JN, Banks RE et al. International cancer seminars: a focus on kidneycancer. Ann Oncol 2016; 27(8): 1382-1385. In this, the second seminar, IARC and NCI convened a workshop in order to ...
Clinically, BHDS is highly heterogeneous even within the same family. The most characteristic features of BHDS are fibrofolliculomas, lung cysts that confer the risk of pneumothorax, and benign or malignant renaltumours. Additionally, several other tumours are discussed to be possibly linked to BHDS including colon and breast cancer, thyroid tumors, and parathyroid adenomas.